In our previous publication, drawing on three GBM transcriptome databases, we showed that the transcript levels of Glut3/Glut14 and Leloir enzymes were elevated in GBM, and that high transcript levels were statistically correlated with poor patient outcomes [5]. This evidence concerns the gene SLC2A3 and glioblastoma.